What does Rittenhouse Ventures invest in?
Rittenhouse Ventures invests most often at Series A and Venture (87% of the rounds on record), in sectors such as Business-to-business, Pharmaceuticals and Cgt.

United States · Investor
Last cheque observed Oct 2026; 17 cheques on record.
Deploying nowNew fund $14M, Mar 2025VC firm
Follow Rittenhouse Ventures and see its new cheques in your feed.Start following
1 cheques in the last 12 months
Mostly Series A and Venture: 87% of its rounds
Sole investor in 1 rounds, median undisclosed
2 exits from the portfolio
Rittenhouse Ventures is a Philadelphia-based, emerging-growth venture capital firmFrom their own website
Every round we can evidence, newest first17 appearances
1 round
1 round
1 round
2 rounds
1 round
2 rounds
1 round
3 rounds
1 round
1 round
3 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration2 named
We also hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From their own portfolio page (on their website)
High QAKickupNoblebiomaterialsPianoS2N HealthTranscendAPVidadiagnosticsWealthhubsolutionsCeceliahealthCoresolutionsincGalenuscareMybitesSmarter-technologiesStationmd
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Companies it backed that were later bought or listed2 in all
An exit counts when it came after the firm's first round in the company. From historical deal records.
The investors most often in the same rounds as Rittenhouse Ventures. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Rittenhouse Ventures put money into.
Rittenhouse Ventures invests most often at Series A and Venture (87% of the rounds on record), in sectors such as Business-to-business, Pharmaceuticals and Cgt.
17 investments on record, 1 of them in the last 12 months. The most recent was in Oct 2026.
Its most recent investments on record: Bites (Series A, Oct 2026), SquareFoot (Series A, Apr 2018) and Energage (Undisclosed round, Oct 2017).
The median round it joins is $15M.
Rarely, if at all: none of its 17 investments on record names it as the lead.
Most of the companies it backs are in the United States (94%) and the United Kingdom (6%).
Yes: it is actively investing, with 1 investments in the last 12 months.
Most often Emerald Stage2 Ventures (11 rounds together) and Innovation Ventures (2 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it